Study of JMKX003142 in healthy Chinese men
Treatments studied
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is for healthy Chinese men to see how the study drug JMKX003142 is processed in the body. You will take the drug by mouth and by vein on separate days to measure how much gets into your blood and how it leaves your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and of Chinese ethnicity.
- You are between 18 and 45 years old.
- You have a healthy weight with a body mass index (BMI) between 19 and 26, and you weigh at least 55 kg (about 121 pounds).
- You are generally healthy with no major medical conditions, and your lab tests, heart rhythm, and other exams are normal.
- You do not have active hepatitis B, C, syphilis, or HIV.
- You do not have a history of stomach or bowel problems that cause nausea, vomiting, diarrhea, or trouble absorbing nutrients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental drug (JMKX003142) interacts with other medications in healthy volunteers. Researchers want to understand whether taking this drug with other common drugs is safe and effective.
This trial tests whether a new drug, JMKX003142, affects the heart's electrical activity (QTc interval) in healthy volunteers. It helps determine if the drug is safe for the heart before testing in patients.
This study checks how a new drug interacts with the body. It is for healthy volunteers to see if the drug is safe and how it works in the body.
This trial tests a drug (JMKX003142) for people with autosomal dominant polycystic kidney disease that is getting worse quickly. It may help slow down kidney damage.
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
This trial tests whether a new drug, JMKX003142, interacts with two other medications (amiodarone and febuxostat) in healthy volunteers. The goal is to understand how these drugs affect each other in the body.
Hear when a new ADPKD (Autosomal Dominant Polycystic Kidney Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.